For more information, visit our Vaccine Confidence Resource Center. In a compelling webinar hosted by the W. Montague Cobb Institute and the U.S. Department of…
For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a study published online Sept. 4 in the Journal of…
(HealthDay News) — Senior residential homes are breeding grounds for antibiotic-resistant bacteria, due to overprescription of antibiotics, a new study says. Stool samples provided by…
(HealthDay News) — The first mpox vaccine doses from the United States are set to arrive next week in the Congo, the epicenter of an…
(HealthDay News) — The World Health Organization on Wednesday made the rare move of declaring an ongoing African outbreak of mpox a global health emergency.…
(HealthDay News) — It’s long been known that popping the antibiotic doxycycline within 72 hours of a risky sexual encounter can greatly reduce a person’s risk…
Expectant mothers who get vaccinated to protect their newborns against respiratory syncytial virus (RSV) are not putting themselves or their babies at risk, new research…
(HealthDay News) — Many sexually transmitted diseases are on the rise in the United States, and a nationwide poll indicates that ignorance about how they’re…
The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people…
(HealthDay News) — Among emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the…